DoubleChecks

What was claimed

Retatrutide fixes sleep apnea, cures diabetes, makes you more conscientious, and sexually irresistible

Our verdict

Inaccurate

Trials reported improved A1C and weight loss in people with type 2 diabetes. These results do not establish a cure, and retatrutide has no approved clinical use. There is no clinical evidence whatsoever that retatrutide affects sexual attractiveness or desirability. This claim has no basis in any published research, clinical trial data, or medical literature about the drug.

Combined assessment15 sourcesChecked Oct 29, 2026

Why this verdict

  • Retatrutide cures diabetes

    Incorrect
    Two assessments reached this conclusion; one differed·Claude: Misleading

  • Retatrutide fixes sleep apnea

    Misleading
    All assessments reached this conclusion

  • Retatrutide makes you sexually irresistible

    Can’t verify
    Three assessments reached this conclusion; two differed·Claude: Incorrect, Claude: Incorrect

  • Retatrutide makes you sexually irresistible

    Can’t verify
    One assessment reached this conclusion

Evidence reviewed

15 sources

Perplexity, Claude and ChatGPT sources are combined here.

health.yahoo.cominvestor.lilly.cominvestor.lilly.comnejm.orgdrugs.comlilly.commedscape.comccjm.orgdiabetes.orgnbcnews.com

Individual assessments

Assessment summary

  • The statement exaggerates trial findings and includes unsupported claims.
  • Retatrutide is investigational and has shown improvements in sleep-apnea severity and blood glucose, but it has not been shown to cure either condition, change conscientiousness, or make people sexually irresistible.health.yahoo.com investor.lilly.com investor.lilly.com

Claims reviewed

Retatrutide cures diabetes

Incorrect
Trials reported improved A1C and weight loss in people with type 2 diabetes. These results do not establish a cure, and retatrutide has no approved clinical use.investor.lilly.com nejm.org

This claim may mislead readers without added context.

Retatrutide fixes sleep apnea

Misleading
Phase 3 trials found substantial reductions in apnea-hypopnea events, not a guaranteed cure or complete resolution. Retatrutide remains investigational and unapproved.health.yahoo.com investor.lilly.com

This claim may mislead readers without added context.

Retatrutide makes you more conscientious

Can’t verify
The cited clinical evidence evaluates weight, glucose control, and sleep apnea, not conscientiousness or personality change.health.yahoo.com investor.lilly.com

Assessment summary

  • The claim makes four distinct assertions about retatrutide.
  • While clinical trials show it significantly reduces sleep apnea severity and improves blood sugar control in type 2 diabetes, the claim uses absolute language ("fixes," "cures") that overstates the evidence.
  • Most critically, there is no credible clinical evidence that retatrutide makes users "more conscientious" or "sexually irresistible"—these claims are entirely unsupported by research.

Claims reviewed

Retatrutide makes you more conscientious

Incorrect
No clinical trials or peer-reviewed research documents that retatrutide increases conscientiousness as a personality trait. While some users report reduced impulsiveness or improved focus related to appetite suppression, this is not the same as increasing conscientiousness, and no systematic evidence supports this claim peptideschedule.com truthinpeptides.com.

This claim may mislead readers without added context.

Retatrutide makes you sexually irresistible

Incorrect
There is no clinical evidence whatsoever that retatrutide affects sexual attractiveness or desirability. This claim has no basis in any published research, clinical trial data, or medical literature about the drug.

This claim may mislead readers without added context.

Retatrutide fixes sleep apnea

Misleading
Clinical trials show retatrutide significantly reduces sleep apnea severity, with breathing interruptions falling by 24-34 events per hour versus 10 with placebo nejm.org physiciansweekly.com. However, 'fixes' implies complete resolution, while the drug reduces but does not eliminate the condition. The term 'reduces severity' is more accurate than 'fixes.'

This claim may mislead readers without added context.

Assessment summary

  • The statement makes multiple strong claims that are not supported by available evidence.
  • High-quality trial reports show retatrutide produces large weight loss and can improve A1C and obstructive sleep apnea metrics, but it is investigational and not a cure for diabetes or a guaranteed fix for sleep apnea nejm.org nejm.org lilly.com.
  • There is no credible evidence that retatrutide increases conscientiousness or makes people "sexually irresistible."

Claims reviewed

Retatrutide cures diabetes

Incorrect
Retatrutide has shown A1C reductions in clinical trials and is being studied for type 2 diabetes, but there is no evidence it cures diabetes; it remains investigational and not a disease cure. nejm.org lilly.com

This claim may mislead readers without added context.

Retatrutide fixes sleep apnea

Misleading
Phase 3 trials reported meaningful reductions in obstructive sleep apnea severity (AHI) versus placebo, but trials report improvement, not a universal or permanent "fix" or cure; the drug is investigational for OSA. nejm.org lilly.com

This claim may mislead readers without added context.

Retatrutide makes you more conscientious

Can’t verify
I found no clinical or preclinical evidence that retatrutide affects personality traits such as conscientiousness; this claim is unsupported in the literature. nejm.org nejm.org

Check your own claim

Paste any statement, headline, or AI answer. Independent assessments check it and compare sources.

Share this result